Table of Contents Table of Contents 2 List of Tables 3 List of Figures 4 Report Guidance 5 Clinical Trials by Region 6 Clinical Trials and Average Enrollment by Country 7 Top Five Countries Contributing to Clinical Trials in Asia-Pacific 9 Top Five Countries Contributing to Clinical Trials in Europe 10 Top Countries Contributing to Clinical Trials in North America 11 Top Countries Contributing to Clinical Trials in Middle East and Africa 12 Top Five Countries Contributing to Clinical Trials in Central and South America 13 Clinical Trials by G7 Countries: Proportion of Influenza B Infections to Infectious Disease Clinical Trials 14 Clinical Trials by Phase in G7 Countries 15 Clinical Trials in G7 Countries by Trial Status 16 Clinical Trials by E7 Countries: Proportion of Influenza B Infections to Infectious Disease Clinical Trials 17 Clinical Trials by Phase in E7 Countries 18 Clinical Trials in E7 Countries by Trial Status 19 Clinical Trials by Phase 20 In Progress Trials by Phase 21 Clinical Trials by Trial Status 22 Clinical Trials by End Point Status 23 Subjects Recruited Over a Period of Time 24 Clinical Trials by Sponsor Type 25 Prominent Sponsors 26 Top Companies Participating in Influenza B Infections Therapeutics Clinical Trials 27 Prominent Drugs 28 Latest Clinical Trials News on Influenza B Infections 29 Dec 17, 2015: Vaxart Announces Enrollment of First Patient in Influenza B Phase 1 Trial 29 Clinical Trial Profile Snapshots 30 Appendix 54 Abbreviations 54 Definitions 54 Research Methodology 55 Secondary Research 55 About GlobalData 56 Contact Us 56 Disclaimer 56 Source 57

List of Tables Influenza B Infections Therapeutics, Global, Clinical Trials by Region, 2016* 6 Influenza B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Influenza B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Influenza B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2016* 9 Influenza B Infections Therapeutics Clinical Trials, Europe, Top Five Countries, 2016* 10 Influenza B Infections Therapeutics Clinical Trials, North America, Top Countries, 2016* 11 Influenza B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries, 2016* 12 Influenza B Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2016* 13 Proportion of Influenza B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14 Influenza B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Influenza B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Influenza B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17 Influenza B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Influenza B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Influenza B Infections Therapeutics, Global, Clinical Trials by Phase, 2016* 20 Influenza B Infections Therapeutics, Global, Clinical Trials In Progress by Phase 2016* 21 Influenza B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Influenza B Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Influenza B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Influenza B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2016* 25 Influenza B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Influenza B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Influenza B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 List of Figures Influenza B Infections Therapeutics, Global, Clinical Trials by Region (%), 2016* 6 Influenza B Infections Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2016* 7 Influenza B Infections Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2016* 8 Influenza B Infections Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2016* 9 Influenza B Infections Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2016* 10 Influenza B Infections Therapeutics Clinical Trials, North America, Top Countries (%), 2016* 11 Influenza B Infections Therapeutics Clinical Trials, Middle East and Africa, Top Countries (%), 2016* 12 Influenza B Infections Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2016* 13 Proportion of Influenza B Infections to Infectious Disease Clinical Trials, G7 Countries (%), 2016* 14 Influenza B Infections Therapeutics, G7 Countries, Clinical Trials by Phase, 2016* 15 Influenza B Infections Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2016* 16 Proportion of Influenza B Infections to Infectious Disease Clinical Trials, E7 Countries (%), 2016* 17 Influenza B Infections Therapeutics, E7 Countries, Clinical Trials by Phase, 2016* 18 Influenza B Infections Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2016* 19 Influenza B Infections Therapeutics, Global, Clinical Trials by Phase (%), 2016* 20 Influenza B Infections Therapeutics, Global, Clinical Trials In Progress by Phase, 2016* 21 Influenza B Infections Therapeutics, Global, Clinical Trials by Trial Status, 2016* 22 Influenza B Infections Therapeutics Clinical Trials, Global, by End Point Status, 2016* 23 Influenza B Infections Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2011-2015 24 Influenza B Infections Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2016* 25 Influenza B Infections Therapeutics Clinical Trials, Global, Key Sponsors, 2016* 26 Influenza B Infections Therapeutics Clinical Trials, Global, Top Companies by Phase, 2016* 27 Influenza B Infections Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2016* 28 GlobalData Methodology 55

GlaxoSmithKline Plc F. Hoffmann-La Roche Ltd. ID Biomedical Corporation Daiichi Sankyo Company, Limited MediVector, Inc. MDVIP, Inc. Biota Pharmaceuticals, Inc. Biological E. Limited Advanced Immunization Technologies ABX-CRO advanced pharmaceutical services Forschungsgesellschaft m.b.H